chrisvoncsefalvay/vaers-outcomes huggingface dataset:
doesn't have a problem when he got the Moderna; nine health threats for death by COVID; nine health threats for death by COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "doesn't have a problem when he got the Moderna"; DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "nine health threats for death by COVID".  Clinical course: It was reported that "Caller is trying to find the RSV vaccine. He heard over a month ago back in May they had distribution of the RSV vaccine or (withheld) in (withheld), He also mentioned that was like one of the last in line to get the COVID vaccine. When he had nine health threats for death by COVID. He doesn't have a problem when he got the Moderna but whenever he takes the Pfizer Covid vaccine was bad for him. He had problems with the Pfizer vaccine every time. He is upset that its across the bay over a month and none of the RSV vaccine are there yet."  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
headache; dizzy; muscle pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), MYALGIA (muscle pain), CHILLS (chills) and HEADACHE (headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included SITAGLIPTIN (JANUVIA [SITAGLIPTIN]), ROSUVASTATIN and HYDROCHLOROTHIAZIDE for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 20-Mar-2021, the patient experienced DIZZINESS (dizzy), MYALGIA (muscle pain) and CHILLS (chills). On 22-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with MECLIZINE HYDROCHLORIDE ongoing since an unknown date at a dose of UNK dosage form and PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, DIZZINESS (dizzy), MYALGIA (muscle pain) and CHILLS (chills) had not resolved and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details not provided.
COVID-19 Vaccine EUA.  Severe pain at injection site approx 6 hours after injection.  Weakness, joint pain, slight headache started around 7:00pm 1/23/21 and continue at the time of this reporting 8:00am 1/24/21 If symptoms persist beyond today I will schedule a visit with my primary care physician.
Significant redness, swelling and heat at injection site 1 week post injection. Approximately 5 inches extending from above the injection site, past it and toward the elbow.  Some tenderness in upper arm and joint discomfort at elbow. No problems at injection site prior to onset of symptoms.
Patient had an injection site reaction that turned red and swelled up to the size of a softball.  The patient was seen by her primary care physician and treated with antihistamines until the reaction resolved.
4 days after my first dose I experienced hematuria. I experienced it again a few weeks later. I received my second shot and 4 days later experienced hematuria for the third time since the first shot.
Crying inconsolably for 6 hours, starting about 9:30PM on 12/16/04 last 5 hours. Pt seen next day exam normal no further problems noted.
Systemic: Lymph Node Swelling-Mild, Additional Details: Patient said that the lump on his arm on the injection site did not go away.
Information has been received from a nurse concerning a female who was vaccinated with the first dose of Gardasil.  Subsequently the patient experienced continuous vaginal discharge and symptoms of a yeast infection.  As of 23-MAY-2007, the patient had not recovered.  Medical attention was sought.  Additional information has been requested.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Mild, Additional Details: Patient refused benedryl or epinephrine. Patietn also refused to go t hospital. patient was monitored from onset of symptoms at 11:58 till 13:02. Patient's vitals were stable BP 111/74 HR 81. Patient escorted home with husband. Instructed to go to hospital is symptoms worsen or or if symptoms do not subside.
Mother states that patient woke up overnight with a rash on her entire face. At the moment the mother gave the patient a dose of liquid BENADRYL and splatter the water on the face. Since she was not improving she took patient to the ER and she was given medicine. She was in observation and was discharged. She had rash for 4 days.
Patient came in almost one week later on 07/09/2021 to the date of vaccination. She said that all of a sudden her right deltoid became hot and swollen literally 15 minutes prior to coming into the pharmacy. It was warm to the touch and raised like a smushy golf ball. She had no other symptoms at that time.  Today, 07/10/2021 she is extremely  exhausted and feels achy all over. Her Right deltoid was still  warm to the touch and raise about a 3 inch diameter. I advised pt to go to a walk in clinic to be seen and take a covid test.
Headaches started after receiving second injection of DNA therapy pfizer injection 5/4/21, first injection was 3/26/21. HAs then increased in intensity and evolved into migraines.Patient also tested positive for covid 19 and influenza b 1/2022.
Syncope approximately 2 minutes after receiving COVID shot.  Diaphoresis and pale in color.
Moderate headache; Some chills; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 60-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 03Nov2021 12:30 (Lot number: FF2589) at the age of 60 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (ongoing), notes: Verbatim: High blood pressure; "High cholesterol" (ongoing), notes: Verbatim: High cholesterol. Concomitant medication(s) included: BENAZEPRIL HCL taken for hypertension (ongoing); LIPTOR [ATORVASTATIN] taken for blood cholesterol (ongoing). Vaccination history included: Bnt162b2 (Dose: 1, Time: 13:45, Anatomical site of injection: Left Arm/ Shoulder, Route of administration: Intramuscular, Batch/Lot number: EL3247), administration date: 24Feb2021, when the patient was 59 years old, for COVID-19 immunization; Bnt162b2 (Dose: 2, Time: 9:30, Anatomical site of injection: Left Arm/ Shoulder, Route of administration: Intramuscular, Batch/Lot number: EL3247), administration date: 16Mar2021, when the patient was 59 years old, for COVID-19 immunization, reaction(s): "Chills", "Fatigue", "moderate headache".  The following information was reported: FATIGUE (non-serious) with onset 03Nov2021 23:00, outcome "recovered" (Nov2021), described as "Fatigue"; HEADACHE (non-serious) with onset 04Nov2021, outcome "recovered" (Nov2021), described as "Moderate headache"; CHILLS (non-serious) with onset 03Nov2021 23:00, outcome "recovered" (Nov2021), described as "Some chills". Therapeutic measures were not taken as a result of fatigue, chills. Therapeutic measures were taken as a result of headache.  Additional information: Patient had no Prior vaccinations and no relevant tests. Chills and fatigue started about 11 hours after the booster shot. I had a mild to moderate headache starting the morning after the booster shot for about a two-day period. Patient took acetaminophen for two days until the headache subsided. I was back to normal after two days. No other issues. I was able to work during this two-day period.  No follow-up attempts are possible. No further information is expected.
22JAN98 mom states pt @ babysitter, was being held became real stiff, eyes rolled back into head, gasping for breath, lasted about 10 seconds;taken to ER;checked by MD;EEG was done;
Information has been received from a 60 year old female patient with hypothyroidism, hypertension, hypercholesterolaemia and acid reflux and no drug reactions or allergies who on 10-DEC-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # and route not reported). Concomitant therapy included simvastatin (manufacturer unknown), captopril, SYNTHROID and ACIPHEX. The consumer reported that on 11-NOV-2010 she developed a fever and chills. She said that "she could not get warm, though she was covered with blankets". She also reported a mild headache. The patient denied any injection site pain, swelling or redness. She said that on 13-DEC-2010 she was fully recovered and she "felt fine". The patient did not seek medical attention. Additional information has been requested.
Severe dizziness. Took meclyzine tablet for dizziness. Continued to stay in bed. Seemed better if lying down.
Rash on left arm and legs; Dose number 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Nov2021 (Lot number: X) at the age of 52 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LORATADINE. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: X, Location of injection: Arm Left), administration date: Feb2021, when the patient was 51 years old, for Covid-19 immunization, reaction(s): "Skin allergy to previous covid vaccines"; Bnt162b2 (Dose Number: 2, Batch/Lot No: X, Location of injection: Arm Left), administration date: Mar2021, when the patient was 51 years old, for Covid-19 immunization, reaction(s): "Skin allergy to previous covid vaccines". The following information was reported: IMMUNISATION (non-serious) with onset Nov2021, outcome "unknown", described as "Dose number 3"; RASH (non-serious) with onset 02Dec2021, outcome "not recovered", described as "Rash on left arm and legs". Therapeutic measures were taken as a result of rash.  Additional information: Patient received Steroid cream as treatment for event rash. Vaccination facility type was pharmacy/drug store. Patient received Loratadine and Steroid cream within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. Patient had no known allergies.  No follow-up attempts are possible. No further information is expected.
fever; pain when urinating; and pain underneaht their left ribs; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (pain when urinating), MUSCULOSKELETAL CHEST PAIN (and pain underneaht their left ribs) and PYREXIA (fever) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-May-2021, the patient experienced DYSURIA (pain when urinating) and MUSCULOSKELETAL CHEST PAIN (and pain underneaht their left ribs). On 16-May-2021, the patient experienced PYREXIA (fever). The patient was treated with IBUPROFEN on 16-May-2021 for Fever, at a dose of 500 milligram twice a day. On 16-May-2021, DYSURIA (pain when urinating) and MUSCULOSKELETAL CHEST PAIN (and pain underneaht their left ribs) had resolved. At the time of the report, PYREXIA (fever) had not resolved.            No concomitant medications were reported. Action taken with mRNA-123 is not applicable.
w/in 5min of vax pt noted to be pale/sallow w/ c/o throat discomfort & emesis placed supine non-responsive cold clammy w/thready pulse, blue around mouth;02 by mask & epi given;taken to ER;vomited;not responsive;
Patient called once home to report significant nose bleeding following vaccination. Patient stated he does not currently take any blood thinners and he does not have a history of nose bleeds. He stated that the flow was starting to slow while he was on the phone with me.
DTAP/IPV given 2 months after 4th dose. DTAP (TRIHIBIT given 12-6-08)
Fever blisters in nostrils; Shingles in the eye; Swollen bar at injection site; Information has been downloaded from regulatory authority (US-CHIRONMA-PHHY2013US140261).  Information has been received from a healthcare professional referring to a 60 years old female patient. The patient's medical history was not provided. The patient's concurrent condition included drug allergy. The patient's concomitant therapies included amlodipine (+) estrogens (+) conjugated (+) medroxyprogesterone acetate (PREMPRO), levothyroxine sodium, duloxetine hydrochloride (CYMBALTA) and sertraline hydrochloride.     On 13-SEP-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (1 dosage form, lot # J003796 and expiration date 28-JUN-2014; strength was unknown) subcutaneously for immunisation. On the same day, the patient was also vaccinated with influenza virus sag 3v vaccine inactivated (FLUVIRIN) (1 dosage form (DF), lot # 1307601 and expiration date 31-MAR-2014; strength was unknown) intramuscularly for immunisation.   On 26-SEP-2013, the patient experienced fever blisters in nostrils, shingles in the eye and swollen bar at injection site. The outcome of the events was reported as recovered. The causality between the events and zoster vaccine live (ZOSTAVAX) was not provided. The causality between the events of fever blisters in nostrils, shingles in the eye and influenza virus sag 3v vaccine inactivated (FLUVIRIN) was assessed as suspected by the reporter. The causality between swollen bar at injection site and influenza virus sag 3v vaccine inactivated (FLUVIRIN) was not provided.  The events of fever blisters in nostrils, shingles in the eye and swollen bar at injection site was considered to be medically significant by the reporter.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1707USA008650:
My arm is hurting/its hurting me bad; I am losing use of my arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 08Feb2022 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 08Feb2022, outcome "unknown", described as "My arm is hurting/its hurting me bad"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 08Feb2022, outcome "unknown", described as "I am losing use of my arm".  COVID-19  Vaccine is a Pfizer product, unspecified COVID-19 Vaccine manufacturer, Dates for COVID-19 Vaccine: (Start: Unspecified Stop: Unspecified. Additional information; The  patient gonna call, we are gonna call back, we can call back we got a bad connection because she is breaking up, I just don't think I understand, just hang up." Further probing could not be done as consumer hung up abruptly. Hence, product details (LOT, expiration date, NDC, UPC), purchase details and other details were unknown and limited information was available over the call. reporter type captured as consumer or other non health professional by default.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
stuffy nose, nose is stuffy and no.matter how much i blow it it still clogs back up with nasty green snot.; I cant smell very good at all but i can still taste some bit; Nasty green snot; This spontaneous case was reported by an other health care professional and describes the occurrence of NASAL CONGESTION (stuffy nose, nose is stuffy and no.matter how much i blow it it still clogs back up with nasty green snot.), ANOSMIA (I cant smell very good at all but i can still taste some bit) and NASAL DISCHARGE DISCOLOURATION (Nasty green snot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (stuffy nose, nose is stuffy and no.matter how much i blow it it still clogs back up with nasty green snot.), ANOSMIA (I cant smell very good at all but i can still taste some bit) and NASAL DISCHARGE DISCOLOURATION (Nasty green snot). At the time of the report, NASAL CONGESTION (stuffy nose, nose is stuffy and no.matter how much i blow it it still clogs back up with nasty green snot.), ANOSMIA (I cant smell very good at all but i can still taste some bit) and NASAL DISCHARGE DISCOLOURATION (Nasty green snot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the reporter  No Treatment Information were provided by the reporter  Company Comment  This case concerns a patient of an unknown age and gender with no reported medical history, who experienced the non-serious unexpected AESI of Anosmia. The event occurred on an unknown date after an unspecified dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a patient of an unknown age and gender with no reported medical history, who experienced the non-serious unexpected AESI of Anosmia. The event occurred on an unknown date after an unspecified dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
This spontaneous report as received from a registered nurse refers to an unknown number of patients of unknown age and gender. Relevant medical history and concomitant medication were not provided. On 29-OCT-2013 the patients were vaccinated with oral ROTATEQ lot number J004874. Dose, route and frequency were not provided. On 29-OCT-2013, the patients were vaccinated with oral ROTATEQ stored as high as 47F for up to 44 hours. No adverse effects were reported. This case was linked to 1311USA008054, 1311USA007704, 1311USA007705, 1311USA007695, 1311USA007696, 1311USA007699, 1311USA007700, 1311USA007701, 1311USA007702, 1311USA007703, 1311USA007698, 1311USA007697, 1311USA008057, 1311USA008058, 1311USA008060, 1311USA008055, 1311USA000906, 1311USA008061, 1311USA008056 (same reporter link). Additional information has been requested.
May 7, 2021 I woke up with severe vertigo and could not walk by myself.  I saw my family Dr. who sent me to the ER for fear of a stroke.
I would like to know why the vaccines are not working against covid-19, my wife, 2 daughters and I have followed the recommendations and we vaccinated and even so we contracted the virus; I would like to know why the vaccines are not working against covid-19, my wife, 2 daughters and I have followed the recommendations and we vaccinated and even so we contracted the virus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I would like to know why the vaccines are not working against covid-19, my wife, 2 daughters and I have followed the recommendations and we vaccinated and even so we contracted the virus". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200015090 same reporter/event/drug, different patient.
Pt. rec vaccines went home started having a little itching. The following morning pt had a quarter size amount of redness and swelling at injection site. Child went to school and around 1:30 pm school called mom. Mom brought child in with 19x16 severe redness and 7x7 swollen area on
Questionable vaccine reaction- positive urticaria throughout trunk right upper and lower extremities and face. Non pruritic. Shots given 3/22/2004. Rash onset 3/31/04-04/01/04. Rash started at MMR injection site. Possible neomycin reaction.
pt recv vax 13JUL98 & 30JUL98 pt came to urgent care w/c/o aching joints & swollen lt knee not r/t injury;
6:40: complains of tingling 5 mins after shot, continued for 15 mins on and off; informed MD; stayed another 15 mins for observation, developed a rash on arm; received 25 mg IM of Benadryl.  Symptoms resolved by 1855.
02/26/03:  Some achiness, otherwise, no significant report.  3/10/03:  Pt complained of back pain, left work because her back "went out". This is historical in this vaccinee.  While home, pt developed joint pain and muscle weakness. From 3/10 to 4/1/03, increasing pain, several MD visits, MRI, rhumatoid profile, HLAB 27 tests. 4/8/03: Pt. continues in pain.  At home, unable to work
Itchy, slightly raised rashes and welts beginning on inner left arm (not outer arm, which was injection site) and spreading to inner right arm and abdomen.  All on left side except for rashes on inner right arm.  Rashes not painful.
Rash (resembling a hundred mosquito bites) appearing around elbows and back of the knee, around midriff, and then neck and back. Disappeared when I took Benadryl but came back once it wore off.
About a week after my 1st dose I developed a rash that looked like shingles on the top of my right wrist. It was very itchy for 5 days and it has subsided. I have photos as needed
The patient was standing with her mother at the front desk/ nurses station scheduling an appointment.  The patient suddenly fell backwards, hitting her head on the floor.  She had a brief loss of consciousness and her pupils dilated and her arms stiffened and shook for less than 10 seconds.  Vital signs were monitored and she was examined by the ARNP and given an ice pack for her head.  She was able to ambulate to her mother's car without difficulty.